Treadmill walking to improve walking and fitness following stroke: a single blinded pilot randomised controlled trial.

Completed

• Conditions: People with stroke; Stroke - Ischaemic; Neurological - Other neurological disorders

• Registration Number: ACTRN12607000412437
• Lead Sponsor: Princess Alexandra Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2007-08-13
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Diagnosis of stroke
Medically stable
Able to walk independently prior to stroke
Are referred for physiotherapy
Have gait deficits on initial assessment
Have sufficient cognition and communication to understand the purpose of the study and give informed consent or mini mental state exam >22
Attain a score of at least 3 on Motor Assessment Scale, Walking
Able to walk on the treadmill with or without assistance of 1 person

Exclusion Criteria

Have any other neurological conditions that may influence their gait (eg. PD, MS)
Have major musculoskeletal disorders that may influence their gait (eg. amputation, fracture, THR)
Have any uncompensated sensory dysfunction that may affect their gait (e.g. blindness)
Have any cardiovascular problems that would limit their participation in physiotherapy

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Walking capacity as measured by distance walked in 6 minutes[For all measures is at baseline, at end of 6 week intervention and 3 months following completion of intervention period.];Spatial temporal gait variables of walking speed, usual and fast measured by GAITRite.[For all measures is at baseline, at end of 6 week intervention and 3 months following completion of intervention period.];Joint angles during overground walking[For all measures is at baseline, at end of 6 week intervention and 3 months following completion of intervention period.]

Secondary Outcome Measures

Name	Time	Method
6 minute walk test distance[All measures are at baseline, at end of 6 week intervention and 3 months following completion of intervention.];peak oxygen uptake during 6 minute walk test.[All measures are at baseline, at end of 6 week intervention and 3 months following completion of intervention.];Walking quality as measured by Visual analogue scale.[all measures will be recorded at baseline, at end of 6 week intervention and 3 months following completion of intervention]